Skip to main content
Recall Canary
Vasopressin 2 Units/2 mL Syringes
← Back to all recalls
DRUG RECALLMODERATE

Vasopressin 2 Units/2 mL Syringes

IntegraDose is recalling Vasopressin 2 Units/2 mL syringes due to subpotency, which may cause the drug to be ineffective.

What to do

Healthcare facilities should immediately check their inventory, quarantine any affected product, and contact the firm to arrange for return.

Recalled
Listed
Updated
Recall No.
D-0593-2026
Agency
FDA
Firm
IntegraDose Compounding Services LLC
Recall ID
99014
Status
ONGOING

Recall at a glance

Quantity recalled
287 units

Why it was recalled

IntegraDose Compounding Services is recalling specific lots of Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride syringes due to the product being subpotent. This lack of potency may result in the drug failing to provide the intended therapeutic effect.

Is mine affected?

Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.

Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride, syringe, IntegraDose Compounding Services, LLC. 3650 Victoria St N…

Lot code
20260327VAS-3, 2026
NDC / UPC
NDC 71139-0190-1

Where it was sold

Distributed nationwide.

Timeline

  1. Firm initiated recall
  2. Publicly announced
  3. Listed on Recall Canary
  4. Summary updated

Other Drug Potency recalls

Other recent recalls from IntegraDose Compounding Services LLC

All recalls from IntegraDose Compounding Services LLC

← Back to all recalls

Editorial summary by Recall Canary · summary updated 2026-06-13 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification